Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett W Stringer

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Molecular Imaging|July 29, 2015
EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging StudySimon Puttick, Brett W Stringer, Bryan W Day, et al.
Journal of Neuro-Oncology|November 25, 2019
Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytomaKok-Siong Chen, Caitlin R Bridges, Zorana Lynton, et al.
Journal of Medicinal Chemistry|February 17, 2017
Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in GlioblastomaQingqing Zhou, Athena F Phoa, Ramzi H Abbassi, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2017
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastomaRoger Gilabert-Oriol, Sebastian G B Furness, Brett W Stringer, et al.
American Journal of Human Genetics|February 13, 2026
SMN1 variants identified by false-positive SMA newborn screening tests: Therapeutic hurdles and functional and epidemiological solutionsBrunhilde Wirth, Joyosmita Das, Heike Kölbel, et al.
Cells|May 13, 2023
Functional Characterisation of the Circular RNA, <i>circHTT(2-6)</i>, in Huntington's DiseaseLaura Gantley, Brett W Stringer, Vanessa M Conn, et al.
Biochemical Pharmacology|November 1, 2015
Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signallingAthena F Phoa, Stephen Browne, Fadi M S Gurgis, et al.
Cells|January 25, 2020
Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D CultureRochelle C J D'Souza, Carolin Offenhäuser, Jasmin Straube, et al.
Molecular Cancer Research : MCR|February 22, 2020
Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and GrowthAnchit Khanna, Julie A I Thoms, Brett W Stringer, et al.
Oncotarget|February 9, 2017
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cellsAmanda Tivnan, Tatjana Heilinger, Joanne M Ramsey, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Molecular Imaging|July 29, 2015
EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging StudySimon Puttick, Brett W Stringer, Bryan W Day, et al.
Journal of Neuro-Oncology|November 25, 2019
Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytomaKok-Siong Chen, Caitlin R Bridges, Zorana Lynton, et al.
Journal of Medicinal Chemistry|February 17, 2017
Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in GlioblastomaQingqing Zhou, Athena F Phoa, Ramzi H Abbassi, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2017
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastomaRoger Gilabert-Oriol, Sebastian G B Furness, Brett W Stringer, et al.
American Journal of Human Genetics|February 13, 2026
SMN1 variants identified by false-positive SMA newborn screening tests: Therapeutic hurdles and functional and epidemiological solutionsBrunhilde Wirth, Joyosmita Das, Heike Kölbel, et al.
Cells|May 13, 2023
Functional Characterisation of the Circular RNA, <i>circHTT(2-6)</i>, in Huntington's DiseaseLaura Gantley, Brett W Stringer, Vanessa M Conn, et al.
Biochemical Pharmacology|November 1, 2015
Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signallingAthena F Phoa, Stephen Browne, Fadi M S Gurgis, et al.
Cells|January 25, 2020
Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D CultureRochelle C J D'Souza, Carolin Offenhäuser, Jasmin Straube, et al.
Molecular Cancer Research : MCR|February 22, 2020
Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and GrowthAnchit Khanna, Julie A I Thoms, Brett W Stringer, et al.
Oncotarget|February 9, 2017
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cellsAmanda Tivnan, Tatjana Heilinger, Joanne M Ramsey, et al.
Pageof 6